Vonoprazan Fumarate Patent Expiration
Vonoprazan Fumarate was first introduced by Phathom Pharmaceuticals Inc
Vonoprazan Fumarate Patents
Given below is the list of patents protecting Vonoprazan Fumarate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Voquezna | US9186411 | Pharmaceutical composition | Aug 11, 2030 | Phathom |
| Voquezna | US7977488 | 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors | Aug 11, 2028 | Phathom |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Vonoprazan Fumarate's patents.
Latest Legal Activities on Vonoprazan Fumarate's Patents
Given below is the list recent legal activities going on the following patents of Vonoprazan Fumarate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Second letter to regulating agency to determine regulatory review period | 01 Mar, 2024 | US7977488 |
| Letter from FDA or Dept of Agriculture re PTE application | 24 Jan, 2024 | US7977488 |
| Initial letter Re: PTE Application to regulating agency | 17 Aug, 2023 | US7977488 |
| Change in Power of Attorney (May Include Associate POA) Critical | 16 Jun, 2023 | US9186411 |
| Email Notification Critical | 16 Jun, 2023 | US9186411 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 20 Apr, 2023 | US9186411 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 20 Dec, 2022 | US7977488 |
| Change in Power of Attorney (May Include Associate POA) Critical | 13 Jul, 2022 | US7977488 |
| Email Notification Critical | 13 Jul, 2022 | US7977488 |
| Correspondence Address Change Critical | 12 Jul, 2022 | US7977488 |
Vonoprazan Fumarate's Family Patents
